{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T01:43:44Z","timestamp":1774057424586,"version":"3.50.1"},"reference-count":5,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","jaad.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jaad.2024.03.051","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T16:11:17Z","timestamp":1714493477000},"page":"519-521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Inflamed rhinophyma treated with topical ivermectin: A randomized controlled study"],"prefix":"10.1016","volume":"91","author":[{"given":"Federica","family":"Dall\u2019Oglio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rita","family":"Nasca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helga","family":"Platania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Micali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jaad.2024.03.051_bib1","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/bjd.18420","article-title":"Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel","volume":"182","author":"Schaller","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2024.03.051_bib2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2147\/CCID.S201290","article-title":"Rhinophyma: prevalence, severity, impact and management","volume":"13","author":"Chauhan","year":"2020","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"16","key":"10.1016\/j.jaad.2024.03.051_bib3","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1080\/14656566.2022.2142907","article-title":"Advances in pharmacotherapy for rosacea: what is the current state of the art?","volume":"23","author":"Dall\u2019Oglio","year":"2022","journal-title":"Expert Opin Pharmacother"},{"issue":"11","key":"10.1016\/j.jaad.2024.03.051_bib4","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1111\/jdv.14437","article-title":"Dual anti-inflammatory and anti-parasitic action of topical ivermectin 1% in papulopustular rosacea","volume":"31","author":"Schaller","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jaad.2024.03.051_bib5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/srt.12979","article-title":"Inter-observer evaluation of erythema-directed photography for the assessment of erythema and telangiectasias in rosacea","volume":"27","author":"Dall\u2019Oglio","year":"2021","journal-title":"Skin Res Technol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224006741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224006741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T02:29:49Z","timestamp":1730341789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962224006741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0190962224006741"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2024.03.051","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflamed rhinophyma treated with topical ivermectin: A randomized controlled study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2024.03.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}